You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 30, 2025

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Hussein Asad1, Timothy Saettele2, Ossama Tawfik3
1Department of Pulmonary and Critical Care, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Navigational bronchoscopy (NB) effectively provides sufficient tissue for programmed death-ligand 1 (PD-L1) testing in non-small cell lung cancer (NSCLC). Only 4% of patients required additional biopsies, demonstrating NB
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: